T Türsz

2.7k citations

38 papers · 1.9k indexed · h-index 14

Impact in

Oncology top 2%
- Vascular Tumors and Angiosarcomas
- CAR-T cell therapy research
Pulmonary and Respiratory Medicine top 1%
- Sarcoma Diagnosis and Treatment

Papers in

Oncology 20
- Vascular Tumors and Angiosarcomas 10
- CAR-T cell therapy research 3
- Cancer Immunotherapy and Biomarkers 3
Pulmonary and Respiratory Medicine 21
- Sarcoma Diagnosis and Treatment 20

Co-authors: Jaap Verweij R. Somers J. Buesa Henning T. Mouridsen Armando Santoro M. van Glabbeke D. Crowther A.T. van Oosterom
Journals: Journal of Clinical Oncology (10 papers)European Journal of Cancer (6 papers)British Journal of Cancer (3 papers)Annals of Oncology (3 papers)Cancer (1 paper)
Partner nations: France Netherlands United Kingdom

In The Last Decade

T Türsz

37 papers receiving 1.8k citations

Peers

Countries citing papers authored by T Türsz

Since Specialization

Citations

This map shows the geographic impact of T Türsz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Türsz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Türsz more than expected).

Fields of papers citing papers by T Türsz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T Türsz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Türsz. The network helps show where T Türsz may publish in the future.

Co-authors

The 25 scholars most cited alongside T Türsz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with T Türsz Line = papers co-authored together T Türsz links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	p53 status correlates with histopathological response in patients with soft tissue sarcomas treated using isolated limb perfusion with TNF-α and melphalan Annals of Oncology ·Jane Muret, M. Yacoub, Philippe Terrier, F. Drusch, A. Laplanche, Catherine Gaudin, Catherine Richon, C. Le Péchoux, Axel Le Cesne, Ferdinand Lejeune, T Türsz, P Fouret, Sylvie Bonvalot, Salem Chouaı̈b	2007	12
2	Intensive induction chemotherapy (CT) without methotrexate (MTX) in adult patients with localized osteosarcoma (LO): Updated results of the Institut Gustave Roussy phase II trial Journal of Clinical Oncology ·Hazem Assi, Marie‐Cécile Le Deley, G. Missenard, Philippe Terrier, C. Le Péchoux, Sylvie Bonvalot, D. Vanel, Jean‐Baptiste Méric, T Türsz, Axel Le Cesne	2004	1
3	p53-dependent G2 arrest associated with a decrease in cyclins A2 and B1 levels in a human carcinoma cell line British Journal of Cancer ·Christophe Badie, Jean Bourhis, Joëlle Sobczak‐Thépot, Hédi Haddada, Marielle Chiron, Michel Janicot, F Janot, T Türsz, Gilles Vassal	2000	42
4	Prognostic Factors for the Outcome of Chemotherapy in Advanced Soft Tissue Sarcoma: An Analysis of 2,185 Patients Treated With Anthracycline-Containing First-Line Regimens—A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study Journal of Clinical Oncology ·M. van Glabbeke, A.T. van Oosterom, J. Wolter Oosterhuis, Henning T. Mouridsen, D. Crowther, R. Somers, Jaap Verweij, Armando Santoro, J. Buesa, T Türsz	1999	442
5	Ewing's family of tumors in adults: multivariate analysis of survival and long-term results of multimodality therapy in 182 patients. Journal of Clinical Oncology ·Karim Fizazi, Nadine Dohollou, Jean‐Yves Blay, Sylvie Guérin, Axel Le Cesne, Fabrice André, P Pouillart, T Türsz, Binh Bui Nguyen	1998	91
6	High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group British Journal of Cancer ·OS Nielsen, P Dombernowsky, H.T. Mouridsen, D. Crowther, Jaap Verweij, J. Buesa, William P. Steward, Søren Daugaard, M. van Glabbeke, A. Kirkpatrick, T Türsz	1998	78
7	First-Line Vinorelbine-Mitoxantrone Combination in Metastatic Breast Cancer Patients Relapsing after an Adjuvant Anthracycline Regimen: Results of a Phase II Study Oncology ·Antonio Llombart‐Cussac, Xavier Pivot, Alba Rhor-Alvarado, Axel Le Cesne, Thierry Le Chevalier, T Türsz, M. Spielmann	1998	11
8	Adjuvant chemotherapy for primary cardiac sarcomas: the IGR experience British Journal of Cancer ·Antonio Llombart‐Cussac, Xavier Pivot, G Contesso, Alba Rhor-Alvarado, J-P. Delord, M. Spielmann, T Türsz, Axel Le Cesne	1998	109
9	Soft tissue sarcomas in HIV-infected adult patients European Journal of Cancer ·Karim Fizazi, Jean Feuillard, Axel Le Cesne, P. Terrier, M. Raphaël, P Pouillart, T Türsz	1996	10
10	The present state of the art in chemotherapy for soft tissue sarcomas in adults: the EORTC point of view Critical Reviews in Oncology/Hematology ·Jaap Verweij, Henning T. Mouridsen, O.S. Nielssen, Penella J. Woll, R. Somers, A.T. van Oosterom, M. van Glabbeke, T Türsz	1995	44
11	Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Journal of Clinical Oncology ·Armando Santoro, T Türsz, Henning T. Mouridsen, Jaap Verweij, W.P. Steward, R. Somers, J. Buesa, Paolo G. Casali, D. Spooner, Elaine M. Rankin	1995	416
12	Combination of BRMs with chemotherapy The American Journal of Medicine ·T Türsz	1995	1
13	Phase II study with Docetaxel (Taxotere®) in advanced soft tissue sarcomas of the adult Annals of Oncology ·Q G van Hoesel, Jaap Verweij, G. Catimel, M. Clavel, Pierre Kerbrat, A.T. van Oosterom, Joseph Kerger, T Türsz, M. van Glabbeke, C van Pottelsberghe, (unknown), (unknown)	1994	116
14	Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression. PubMed ·Abdelmajid Zyad, Jean Bénard, T Türsz, Robert Clarke, Salem Chouaı̈b	1994	73
15	Phase II study of fotemustine in advanced soft tissue sarcomas European Journal of Cancer ·Pierre Kerbrat, R. Somers, Jaap Verweij, D. Crowther, T Türsz, Antonio Santoro, W.P. Steward, M.A. Lentz, M. van Glabbeke, H.T. Mouridsen	1993	3
16	Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Journal of Clinical Oncology ·William P. Steward, Jaap Verweij, R. Somers, D. Spooner, Pierre Kerbrat, M. Clavel, D. Crowther, Jacques Rouëssé, T Türsz, Elias Tueni	1993	115
17	Chemotherapy in the multidisciplinary approach to soft tissue sarcomas Annals of Oncology ·Jaap Verweij, A.T. van Oosterom, R. Somers, Armando Santoro, Jacques Rouëssé, Jan Keizer, T Türsz, Penella J. Woll, William P. Steward, J. Buesa, Pierre Kerbrat, D. Wagener, V. Bramwell, D. Thomas, M. van Glabbeke, Henning T. Mouridsen	1992	18
18	A phase II study of the combination of carboplatin and ifosfamide in previously untreated metastatic small cell lung carcinoma Cancer ·Thierry Le Chevalier, Fabienne Thomas, Rosana Subirana, P Baldeyrou, Pierre Ruffiè, T Türsz, R. Arriagada, M. Chazard	1991	8
19	[Factors of severity in placental choriocarcinoma]. PubMed ·Ben Ayed F, Daniel Bellet, N Badri, Malte Spielmann, Droz Jp, T Türsz, Amiel Jl	1982	2
20	HLA phenotypes in long-term survivors treated with BCG immunotherapy for childhood ALL. BMJ ·T Türsz, J Hors, Marta M. Lipinski, J L Aamiel	1978	4

About T Türsz

T Türsz is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Gastroenterology, Dermatology and Neurology, having authored 38 papers that have together received 1.9k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (20 papers), Vascular Tumors and Angiosarcomas (10 papers), Virus-based gene therapy research (4 papers), CAR-T cell therapy research (3 papers), Gastrointestinal Tumor Research and Treatment (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cardiac tumors and thrombi (3 papers) and Neuroblastoma Research and Treatments (3 papers). The work is most often cited by research in Oncology (1.2k citations), Pulmonary and Respiratory Medicine (1.5k citations), Gastroenterology (155 citations), Cardiology and Cardiovascular Medicine (542 citations) and Pathology and Forensic Medicine (351 citations). T Türsz has collaborated with scholars based in France, Netherlands and United Kingdom. Frequent co-authors include Jaap Verweij, R. Somers, J. Buesa, Henning T. Mouridsen, Armando Santoro, M. van Glabbeke, D. Crowther, A.T. van Oosterom, D. Spooner and J. Wolter Oosterhuis. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, British Journal of Cancer, Annals of Oncology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact